<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04692792</url>
  </required_header>
  <id_info>
    <org_study_id>CMUH109-REC1-161</org_study_id>
    <nct_id>NCT04692792</nct_id>
  </id_info>
  <brief_title>Efficacy Evaluation of Dai Dai Flower on Body Weight</brief_title>
  <official_title>Efficacy Evaluation of Dai Dai Flower on Body Weight</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TCI Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TCI Co., Ltd.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the Dai Dai flower extract on body weight control&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 4, 2021</start_date>
  <completion_date type="Actual">June 15, 2021</completion_date>
  <primary_completion_date type="Actual">March 6, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The change of body weight</measure>
    <time_frame>Change from Baseline body weight at 8 weeks</time_frame>
    <description>The body weight (kg) was assessed by InBody.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The change of BMI</measure>
    <time_frame>Change from Baseline BMI at 8 weeks</time_frame>
    <description>The BMI was assessed by InBody.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The change of body fat mass</measure>
    <time_frame>Change from Baseline body fat mass at 8 weeks</time_frame>
    <description>The body fat mass (kg) was assessed by InBody.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of visceral fat mass</measure>
    <time_frame>Change from Baseline visceral fat mass at 8 weeks</time_frame>
    <description>The visceral fat mass (kg) was assessed by InBody.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of waist-hip ratio</measure>
    <time_frame>Change from Baseline waist-hip ratio at 8 weeks</time_frame>
    <description>The waist-hip ratio was assessed by measuring tape.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of basal metabolic rate</measure>
    <time_frame>Change from Baseline basal metabolic rate at 8 weeks</time_frame>
    <description>The basal metabolic rate was assessed by InBody.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of AST</measure>
    <time_frame>Change from Baseline AST at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of aspartate transaminase (AST)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of ALT</measure>
    <time_frame>Change from Baseline ALT at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of alanine aminotransferase (ALT)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of Creatinine</measure>
    <time_frame>Change from Baseline creatinine at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of creatinine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of BUN</measure>
    <time_frame>Change from Baseline BUN at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of blood urea nitrogen (BUN)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of fasting glycemia</measure>
    <time_frame>Change from Baseline fasting glycemia at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of fasting glycemia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of total cholesterol</measure>
    <time_frame>Change from Baseline total cholesterol at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of total cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of triglyceride</measure>
    <time_frame>Change from Baseline triglyceride at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of triglyceride</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of HDL-cholesterol</measure>
    <time_frame>Change from Baseline HDL-cholesterol at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of HDL-cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of LDL-cholesterol</measure>
    <time_frame>Change from Baseline LDL-cholesterol at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of LDL-cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of insulin</measure>
    <time_frame>Change from Baseline insulin at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of adiponectin</measure>
    <time_frame>Change from Baseline adiponectin at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of adiponectin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of leptin</measure>
    <time_frame>Change from Baseline leptin at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of leptin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of IFN-γ</measure>
    <time_frame>Change from Baseline IFN-γ at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of IFN-γ</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of IL-2</measure>
    <time_frame>Change from Baseline IL-2 at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of IL-2</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The change of IL-1beta</measure>
    <time_frame>Change from Baseline IL-1beta at 8 weeks</time_frame>
    <description>Venous blood was sampled to measure concentrations of IL-1beta</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Gastroenterology</condition>
  <arm_group>
    <arm_group_label>Placebo drink</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Dai Dai flower drink</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo drink</intervention_name>
    <description>consume 1 bottle (50 mL) per day for 8 weeks</description>
    <arm_group_label>Placebo drink</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dai Dai flower drink</intervention_name>
    <description>consume 1 bottle (50 mL) per day for 8 weeks</description>
    <arm_group_label>Dai Dai flower drink</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy male or female aged between 20 and 60 years old&#xD;
&#xD;
          -  Body mass index (BMI) ≥ 24 (kg/m^2) or body fat mass ≥ 25%&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
&#xD;
          -  Implementation in weight loss programs, consumption drugs or supplements for weight&#xD;
             control before 3 months of this study&#xD;
&#xD;
          -  Participate weight control or fat loss human studies before 3 months of this study&#xD;
&#xD;
          -  History of cardiovascular disease, liver disease, kidney disease, endocrine disease,&#xD;
             or other major organic diseases (according to subjects reporting).&#xD;
&#xD;
          -  Person who has received major surgery or bariatric surgery (according to medical&#xD;
             history).&#xD;
&#xD;
          -  Person who has received constant drug use.&#xD;
&#xD;
          -  People with mental illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hsiu-Mei Chiang, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>China Medical University, China</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>China Medical University</name>
      <address>
        <city>Taichung</city>
        <zip>404</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>December 29, 2020</study_first_submitted>
  <study_first_submitted_qc>December 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 5, 2021</study_first_posted>
  <last_update_submitted>August 3, 2021</last_update_submitted>
  <last_update_submitted_qc>August 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity</keyword>
  <keyword>Weight control</keyword>
  <keyword>Dai Dai flower</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

